Optimizing treatment allocation in randomized clinical trials by leveraging baseline covariates
From MaRDI portal
Publication:6589218
DOI10.1111/biom.13914zbMATH Open1543.62654MaRDI QIDQ6589218
Zhiwei Zhang, Aiyi Liu, Wei Zhang
Publication date: 19 August 2024
Published in: Biometrics (Search for Journal in Brave)
Cites Work
- Unnamed Item
- Handling covariates in the design of clinical trials
- Unified methods for censored longitudinal data and causality
- Weak convergence and empirical processes. With applications to statistics
- Sharp instruments for classifying compliers and generalizing causal effects
- Semiparametric theory and missing data.
- On the covariate-adjusted estimation for an overall treatment difference with data from a randomized comparative clinical trial
- Optimal Allocation to Treatment Groups under Variance Heterogeneity
- Improving Efficiency of Inferences in Randomized Clinical Trials Using Auxiliary Covariates
- The central role of the propensity score in observational studies for causal effects
- Optimum biased coin designs for sequential clinical trials with prognostic factors
- Asymptotic Statistics
- The Comparison of Designs for Sequential Clinical Trials with Covariate Information
- Double/debiased machine learning for treatment and structural parameters
- The Elements of Statistical Learning
- Machine learning methods for leveraging baseline covariate information to improve the efficiency of clinical trials
- Empirical efficiency maximization: improved locally efficient covariate adjustment in randomized experiments and survival analysis
- Simple, efficient estimators of treatment effects in randomized trials using generalized linear models to leverage baseline variables
This page was built for publication: Optimizing treatment allocation in randomized clinical trials by leveraging baseline covariates
